According to BELLUS Health's latest financial reports and stock price the company's current Operating Margin is -475,125.00%. At the end of 2022 the company had an Operating Margin of -475,125.00%.
Year | Operating Margin | Change |
---|---|---|
2022 | -475,125.00% | 6.44% |
2021 | -446,393.75% | 110.85% |
2020 | -211,713.33% | 114.99% |
2019 | -98,474.29% | 279.41% |
2018 | -25,954.29% | 2262.08% |
2017 | -1,098.79% | 839.9% |
2016 | -116.90% | -1344.51% |
2015 | 9.39% | -111.07% |
2014 | -84.89% | 97.23% |
2013 | -43.04% | -92.49% |
2012 | -573.11% | 880.55% |
2011 | -58.45% | -90.42% |
2010 | -610.09% | -91.4% |
2009 | -7,092.24% | -14.11% |
2008 | -8,257.36% | 53.49% |
2007 | -5,379.76% | 128.12% |
2006 | -2,358.31% | 10.28% |
2005 | -2,138.42% | -94.61% |
2004 | -39,699.22% | |
2002 | -391.10% | 1156.36% |
2001 | -31.13% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.